Executive summary
A diagnostic that builds the evidence baseline for product portfolio rationalization: what each product really earns, who uses it, what it costs to support, what depends on it and how well it fits the strategy.
What is inside
What the diagnostic covers
The asset walks a diagnostic team through scoping the portfolio, assembling product-level economics that reconcile to finance, building usage and dependency evidence, attesting strategic fit, and rating the quality of every piece of evidence before the baseline is accepted. It ends with a gap register, a baseline fact pack and a formal handover into the readiness assessment that follows it in the pathway.
- Scope: the product set in question, the five baseline lenses and the evidence standard the pathway will rely on
- Product economics beyond standard gross margin, reconciled to the audited accounts
- Usage and demand evidence per product and line, including trend and concentration
- Support cost and complexity signals that standard costing hides
- Dependencies (contracts, shared components, channel listings) that constrain retirement choices
- Strategic fit evidence and who attests it
- An evidence quality rating for every fact, a gap register with owners, and a baseline acceptance gate